Literature DB >> 9392537

Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma.

I K Daftari1, D H Char, L J Verhey, J R Castro, P L Petti, W J Meecham, S Kroll, E A Blakely.   

Abstract

PURPOSE: The purpose of this investigation is to delineate the risk factors in the development of neovascular glaucoma (NVG) after helium-ion irradiation of uveal melanoma patients and to propose treatment technique that may reduce this risk. METHODS AND MATERIALS: 347 uveal melanoma patients were treated with helium-ions using a single-port treatment technique. Using univariate and multivariate statistics, the NVG complication rate was analyzed according to the percent of anterior chamber in the radiation field, tumor size, tumor location, sex, age, dose, and other risk factors. Several University of California San Francisco-Lawrence Berkeley National Laboratory (LBNL) patients in each size category (medium, large, and extralarge) were retrospectively replanned using two ports instead of a single port. By using appropriate polar and azimuthal gaze angles or by treating patients with two ports, the maximum dose to the anterior segment of the eye can often be reduced. Although a larger volume of anterior chamber may receive a lower dose by using two ports than a single port treatment. We hypothesize that this could reduce the level of complications that result from the irradiation of the anterior chamber of the eye. Dose-volume histograms were calculated for the lens, and compared for the single and two-port techniques.
RESULTS: NVG developed in 121 (35%) patients. The risk of NVG peaked between 1 and 2.5 years posttreatment. By univariate and multivariate analysis, the percent of lens in the field was strongly correlated with the development of NVG. Other contributing factors were tumor height, history of diabetes, and vitreous hemorrhage. Dose-volume histogram analysis of single-port vs. two-port techniques demonstrate that for some patients in the medium and large category tumor groups, a significant decrease in dose to the structures in the anterior segment of the eye could have been achieved with the use of two ports.
CONCLUSION: The development of NVG after helium-ion irradiation is correlated to the amount of lens, anterior chamber in the treatment field, tumor height, proximity to the fovea, history of diabetes, and the development of vitreous hemorrhage. Although the influence of the higher LET deposition of helium-ions is unclear, this study suggests that by reducing the dose to the anterior segment of the eye may reduce the NVG complications. Based on this retrospective analysis of LBNL patients, we have implemented techniques to reduce the amount of the anterior segment receiving a high dose in our new series of patients treated with protons using the cyclotron at the UC Davis Crocker Nuclear Laboratory (CNL).

Entities:  

Keywords:  NASA Discipline Radiation Health; Non-NASA Center

Mesh:

Substances:

Year:  1997        PMID: 9392537     DOI: 10.1016/s0360-3016(97)00557-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Retrospective study and review of ocular radiation side effects following external-beam Cobalt-60 radiation therapy in 37 dogs and 12 cats.

Authors:  Chantale L Pinard; Anthony J Mutsaers; Monique N Mayer; J Paul Woods
Journal:  Can Vet J       Date:  2012-12       Impact factor: 1.008

2.  Proton beam radiotherapy of uveal melanoma.

Authors:  Bertil Damato; Andrzej Kacperek; Doug Errington; Heinrich Heimann
Journal:  Saudi J Ophthalmol       Date:  2013-07

3.  Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture.

Authors:  B Damato
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

4.  Proton therapy for uveal melanomas and other eye lesions.

Authors:  J E Munzenrider
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

5.  Lauriston S. Taylor Lecture on radiation protection and measurements: what makes particle radiation so effective?

Authors:  Eleanor A Blakely
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

6.  Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.

Authors:  Alexander Böker; Daniel Pilger; Dino Cordini; Ira Seibel; Aline I Riechardt; Antonia M Joussen; Nikolaos E Bechrakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-16       Impact factor: 3.117

7.  Metastasis rates and sites after treatment for choroidal melanoma by proton beam irradiation or by enucleation.

Authors:  Chryssanthi Koutsandrea; Marilita M Moschos; Michael Dimissianos; Gerasimos Georgopoulos; Ioannnis Ladas; Michael Apostolopoulos
Journal:  Clin Ophthalmol       Date:  2008-12

Review 8.  Current and emerging treatment options for uveal melanoma.

Authors:  Patricia Rusa Pereira; Alexandre Nakao Odashiro; Li-Anne Lim; Cristina Miyamoto; Paula L Blanco; Macanori Odashiro; Shawn Maloney; Dominique F De Souza; Miguel N Burnier
Journal:  Clin Ophthalmol       Date:  2013-08-22

9.  Visual outcomes of proton beam therapy for choroidal melanoma at a single institute in the Republic of Korea.

Authors:  Su-Kyung Jung; Young-Hoon Park; Dong-Ho Shin; Hak-Soo Kim; Jong-Hwi Jung; Tae-Hyun Kim; Sung Ho Moon
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

Review 10.  Non-Cancer Effects following Ionizing Irradiation Involving the Eye and Orbit.

Authors:  Juliette Thariat; Arnaud Martel; Alexandre Matet; Olivier Loria; Laurent Kodjikian; Anh-Minh Nguyen; Laurence Rosier; Joël Herault; Sacha Nahon-Estève; Thibaud Mathis
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.